Compare Enbridge Inc (ENB) vs Edwards Lifesciences Corporation Common Stock (EW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enbridge Inc vs Edwards Lifesciences Corporation Common Stock — how do they compare? Enbridge Inc trades at $46.55 (market cap $103.38B), while Edwards Lifesciences Corporation Common Stock trades at $83.49 (market cap $48.56B). The key difference: Enbridge Inc is far larger — about 2.1× Edwards Lifesciences Corporation Common Stock's market cap, and Enbridge Inc pays a 6.02% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| ENB | EW | |
|---|---|---|
Market Cap | $103.38B | $48.56B |
Volume | 3,684,305 | 6,520,488 |
Sector | Energy | Health |
52-Week High | $58.04 | $95.18 |
52-Week Low | $45.23 | $72.65 |
Typical Hold Time | 91 Days | — |
Enterprise Value | $185.39B | $45.01B |
Dividend Yield | 6.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENB trades at $45.89, down 1.4% on the day, with a bearish technical signal but strong recent earnings beats. The company posted $65.19B in 2025 revenue, with net income of $7.49B and a 7.34% margin. Analysts maintain a consensus buy rating with a $61.63 price target, highlighting a 6% dividend yield and robust cash flow from operations of $12.27B.
Outlook is positive due to consistent EBITDA growth, a $41B project backlog, and defensive midstream assets, though risks include high debt levels and sensitivity to interest rates. The stock offers value with a P/E of 25.54 and P/S of 1.73, supported by institutional interest and dividend stability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →
